Mayank Bansal, CFA
Mayank Bansal is a CFA Charterholder and heads the Equity Research team at Kapitales Research, with over 5 years of experience analysing global equity markets. He leads fundamental, data-driven research combining rigorous financial analysis with macro trends.
3 ASX Stocks to Watch Following Key Corporate Announcements
Highlights:
Several Australian-listed companies have released announcements covering shareholder meetings, exploration results and business performance. These updates provide insights into corporate governance, resource development and commercial growth. The following three stocks are in focus based on their latest announcements and the share prices provided. Stocks in Focus
Annual General Meeting Scheduled for November
Berkeley Energia Limited announced on 9 October 2026 that its annual general meeting would take place on 18 November 2026 at 11:00 am AWST in Perth, Western Australia. Shareholders will consider the company's annual report for the financial year ended 30 June 2026, vote on its remuneration report and decide on the re-election of Adam Parker as a director. They will also consider the election of José Bogas Gálvez, who joined the board on 27 July 2026. The company encouraged shareholders to review the meeting materials and submit proxy forms by 11:00 am AWST on 16 November 2026. The meeting is planned as an in-person event.
Exploration Results Strengthen Resource Potential
Omega Oil & Gas Limited reported on 12 October 2026 that its Canyon-4 appraisal well delivered the strongest results among its Canyon wells to date in Queensland's Taroom Trough. The well intersected 589 metres of gross oil and gas-bearing formations, including 197 metres of aggregate net pay. Average porosity in the primary Canyon Sandstone target reached 12.1%, compared with 7.4% at Canyon-1. The company also reported oil indicators in core samples and gas bubbling from recovered material. Omega is integrating geological, core and wireline data to refine its reservoir model, with an updated resource assessment targeted for the first quarter of 2027. Horizontal appraisal wells designed to test commercial flow potential are planned for the first half of 2027.
Quarterly Sales Contracts Support Revenue Growth
Cogstate Ltd released its first-quarter FY2027 business update on 12 October 2026, reporting US$25.1 million in sales contracts executed during the September quarter, compared with US$21.42 million a year earlier. Five Phase 3 clinical trials involving bipolar disorder or depression contributed more than 80% of the quarter's contract value. Total contracted revenue reached US$143.7 million at 30 September 2026, up 41% from US$101.8 million in the previous corresponding period. Contracted revenue for FY2027 increased to US$56.8 million, representing 45% growth year-on-year. The company attributed its performance partly to its partnerships with clinical technology providers, which help sponsors access its digital cognitive assessment expertise.
Conclusion
The announcements highlight developments in corporate governance, resource appraisal and clinical trial services. Investors may monitor upcoming shareholder decisions, further exploration results and the conversion of contracted sales into recognised revenue when assessing these companies' progress.
Note- All data presented is based on information available at the time of writing.
Disclaimer for Kapitales Research
The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.Disclosure: The information mentioned above has been sourced from the company reports and a third-party database, i.e. Koyfin. Investors are advised to use strict stop-loss to protect their investments in case of any unfavorable/uncertain market events.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au